Switching patients from cinacalcet to etelcalcetide: evaluation of predictors of efficacy in a retrospective cohort study

Read full text
Authors: E. V. Parshina, R. P. Gerasinchuk, A. Y. Zemchenkov, A. B. Zulkarnaev
Cited by: 1
References: 29

Abstract

BACKGROUND: The prevalence of SHPT depends on control strategy and target level of PTH. There is insufficient data for a justified choice of goals and strategy for the SHPT correction. AIM: A retrospective, multicenter, cohort study was conducted to assess the ethelcalcetide efficacy after six months in real world practice. The study sought to identify whether MBD-CKD characteristics are predictive of achieving the goals. MATERIALS AND METHODS: A study included 302 patients in 20 dialysis units in St. Petersburg. The primary endpoint was the proportion of patients who reached the target of PTH (300-599 pg/ml). The secondary endpoint was an absolute and relative decrease in PTH. The results were compared in subgroups with PTH (1000 pg/ml: 79% vs. 36%, p

Fields of Study & Subjects

Parathyroid Disorders and Treatments Thyroid and Parathyroid Surgery Dialysis and Renal Disease Management

Publication details

Journal / source
Problems of Endocrinology
Publisher
Endocrinology Research Centre
Volume
71
Issue
6
Pages
4–14
Publication date
18 January 2026
Language
RU